• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半乳糖凝集素 1-A:组织修复与纤维化之间的关键调节因子。

Galectin 1-A Key Player between Tissue Repair and Fibrosis.

机构信息

Faculty of Medicine, Vasile Goldis Western University of Arad, 310414 Arad, Romania.

"Aurel Ardelean" Institute of Life Sciences, Vasile Goldis Western University of Arad, 310414 Arad, Romania.

出版信息

Int J Mol Sci. 2022 May 16;23(10):5548. doi: 10.3390/ijms23105548.

DOI:10.3390/ijms23105548
PMID:35628357
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9142121/
Abstract

Galectins are ten family members of carbohydrate-binding proteins with a high affinity for β galactose-containing oligosaccharides. Galectin-1 (Gal-1) is the first protein discovered in the family, expressed in many sites under normal and pathological conditions. In the first part of the review article, we described recent advances in the Gal-1 modulatory role on wound healing, by focusing on the different phases triggered by Gal-1, such as inflammation, proliferation, tissue repair and re-epithelialization. On the contrary, Gal-1 persistent over-expression enhances angiogenesis and extracellular matrix (ECM) production via PI3K/Akt pathway activation and leads to keloid tissue. Therefore, the targeted Gal-1 modulation should be considered a method of choice to treat wound healing and avoid keloid formation. In the second part of the review article, we discuss studies clarifying the role of Gal-1 in the pathogenesis of proliferative diabetic retinopathy, liver, renal, pancreatic and pulmonary fibrosis. This evidence suggests that Gal-1 may become a biomarker for the diagnosis and prognosis of tissue fibrosis and a promising molecular target for the development of new and original therapeutic tools to treat fibrosis in different chronic diseases.

摘要

半乳糖凝集素是具有高亲和力结合β半乳糖苷糖的十大家族成员的碳水化合物结合蛋白。半乳糖凝集素-1(Gal-1)是该家族中发现的第一种蛋白质,在正常和病理条件下在许多部位表达。在综述文章的第一部分,我们描述了 Gal-1 对伤口愈合的调节作用的最新进展,重点介绍了 Gal-1 触发的不同阶段,如炎症、增殖、组织修复和再上皮化。相反,Gal-1 的持续过表达通过 PI3K/Akt 通路的激活增强血管生成和细胞外基质(ECM)的产生,导致瘢痕组织。因此,靶向 Gal-1 调节应被视为治疗伤口愈合和避免瘢痕形成的首选方法。在综述文章的第二部分,我们讨论了阐明 Gal-1 在增生性糖尿病视网膜病变、肝脏、肾脏、胰腺和肺纤维化发病机制中的作用的研究。这一证据表明,Gal-1 可能成为组织纤维化的诊断和预后的生物标志物,以及开发用于治疗不同慢性疾病纤维化的新的和原创治疗工具的有前途的分子靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/9142121/88d964e9b392/ijms-23-05548-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/9142121/2ecedb98a198/ijms-23-05548-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/9142121/88d964e9b392/ijms-23-05548-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/9142121/2ecedb98a198/ijms-23-05548-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/9142121/88d964e9b392/ijms-23-05548-g002.jpg

相似文献

1
Galectin 1-A Key Player between Tissue Repair and Fibrosis.半乳糖凝集素 1-A:组织修复与纤维化之间的关键调节因子。
Int J Mol Sci. 2022 May 16;23(10):5548. doi: 10.3390/ijms23105548.
2
Role of galectins in re-epithelialization of wounds.半乳糖凝集素在伤口再上皮化中的作用。
Ann Transl Med. 2014 Sep;2(9):89. doi: 10.3978/j.issn.2305-5839.2014.09.09.
3
Role of galectin-3 in autoimmune and non-autoimmune nephropathies.半乳糖凝集素-3 在自身免疫性和非自身免疫性肾病中的作用。
Autoimmun Rev. 2017 Jan;16(1):34-47. doi: 10.1016/j.autrev.2016.09.023. Epub 2016 Sep 23.
4
Galectin-2 and -4, but not galectin-1, promote intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism.半乳糖凝集素-2和-4而非半乳糖凝集素-1,通过一种不依赖转化生长因子-β(TGF-β)的机制促进体外肠上皮伤口愈合。
Inflamm Bowel Dis. 2008 Oct;14(10):1366-72. doi: 10.1002/ibd.20499.
5
Regulation of wound healing and fibrosis by galectins.半乳糖凝集素调控创伤愈合和纤维化。
J Mol Med (Berl). 2022 Jun;100(6):861-874. doi: 10.1007/s00109-022-02207-1. Epub 2022 May 19.
6
Galectin-1 and Galectin-3 and Their Potential Binding Partners in the Dermal Thickening of Keloid Tissues.半乳糖凝集素-1和半乳糖凝集素-3及其在瘢痕疙瘩组织真皮增厚中的潜在结合伴侣
Am J Dermatopathol. 2019 Mar;41(3):193-204. doi: 10.1097/DAD.0000000000001284.
7
Galectins-3 and -7, but not galectin-1, play a role in re-epithelialization of wounds.半乳糖凝集素-3和-7而非半乳糖凝集素-1在伤口再上皮化过程中发挥作用。
J Biol Chem. 2002 Nov 1;277(44):42299-305. doi: 10.1074/jbc.M200981200. Epub 2002 Aug 22.
8
Galectin-1 is a new fibrosis protein in type 1 and type 2 diabetes.半乳糖凝集素-1 是 1 型和 2 型糖尿病中的一种新的纤维化蛋白。
FASEB J. 2019 Jan;33(1):373-387. doi: 10.1096/fj.201800555RR. Epub 2018 Jul 5.
9
Galectin-1: a small protein with major functions.半乳糖凝集素-1:一种具有主要功能的小蛋白。
Glycobiology. 2006 Nov;16(11):137R-157R. doi: 10.1093/glycob/cwl025. Epub 2006 Jul 13.
10
In silico-based Approach to Investigate the Ability of PEGylated Rapamycin to Inhibit Galectin-3.基于计算机模拟的方法研究聚乙二醇化雷帕霉素抑制半乳糖凝集素-3的能力。
Curr Drug Discov Technol. 2021;18(3):451-456. doi: 10.2174/1570163817666200122162042.

引用本文的文献

1
Inflammaging-Driven Osteoporosis: Is a Galectin-Targeted Approach Needed?炎症衰老驱动的骨质疏松症:是否需要靶向半乳糖凝集素的方法?
Int J Mol Sci. 2025 Jul 4;26(13):6473. doi: 10.3390/ijms26136473.
2
Galectin-1 in Cardiovascular Pathogenesis: Unraveling Dual Roles and Mechanistic Insights in Emerging Research.半乳糖凝集素-1在心血管发病机制中的作用:新兴研究中双重作用及机制的解析
Medicina (Kaunas). 2025 May 30;61(6):1020. doi: 10.3390/medicina61061020.
3
Endogenous Galectin-8 protects against Th17 infiltration and fibrosis following acute kidney injury.

本文引用的文献

1
Galectin-1 and platelet factor 4 (CXCL4) induce complementary platelet responses in vitro.半乳糖凝集素-1 和血小板因子 4(CXCL4)在体外诱导互补的血小板反应。
PLoS One. 2021 Jan 7;16(1):e0244736. doi: 10.1371/journal.pone.0244736. eCollection 2021.
2
Galectin-1 production is elevated in hypertrophic scar.Galectin-1 的产量在增生性瘢痕中升高。
Wound Repair Regen. 2021 Jan;29(1):117-128. doi: 10.1111/wrr.12869. Epub 2020 Oct 26.
3
Galectin-1 Facilitates Macrophage Reprogramming and Resolution of Inflammation Through IFN-β.
内源性半乳糖凝集素-8可预防急性肾损伤后的Th17细胞浸润和纤维化。
Mol Med. 2025 May 16;31(1):192. doi: 10.1186/s10020-025-01245-y.
4
Study on effect of pancreatic kininogenase on diabetic nephropathy-induced fibrosis via Notch1/Hes1/Pten/Akt signaling pathway.胰激肽原酶通过Notch1/Hes1/Pten/Akt信号通路对糖尿病肾病诱导的纤维化作用的研究
BMC Nephrol. 2025 Apr 17;26(1):196. doi: 10.1186/s12882-025-04050-1.
5
Histological signatures map anti-fibrotic factors in mouse and human lungs.组织学特征图谱揭示小鼠和人类肺部的抗纤维化因子。
Nature. 2025 May;641(8064):993-1004. doi: 10.1038/s41586-025-08727-3. Epub 2025 Mar 19.
6
Extracellular Matrix Proteins Improve Risk Prediction in Patients Undergoing Transcatheter Aortic Valve Replacement.细胞外基质蛋白可改善经导管主动脉瓣置换术患者的风险预测。
J Am Heart Assoc. 2025 Mar 4;14(5):e037296. doi: 10.1161/JAHA.124.037296. Epub 2025 Feb 26.
7
Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling.血清半乳糖凝集素-1作为代谢功能障碍相关脂肪性肝病诊断生物标志物的可行性:一项采用便利抽样法对部分中国人群的研究。
Biomedicines. 2025 Feb 10;13(2):425. doi: 10.3390/biomedicines13020425.
8
Galectin Plasmatic Levels Reveal a Cluster Associated with Disease Aggressiveness and Kidney Damage in Multiple Myeloma Patients.半乳糖凝集素血浆水平揭示了与多发性骨髓瘤患者疾病侵袭性和肾损伤相关的一个集群。
Int J Mol Sci. 2024 Dec 17;25(24):13499. doi: 10.3390/ijms252413499.
9
Molecular landscape of kidney allograft tissues data integration portal (NephroDIP): a curated database to improve integration of high-throughput kidney transplant datasets.肾移植组织数据集成门户(NephroDIP)的分子图谱:一个经过精心整理的数据库,可提高高通量肾移植数据集的集成水平。
Front Immunol. 2024 Sep 27;15:1469500. doi: 10.3389/fimmu.2024.1469500. eCollection 2024.
10
Screening of active components in and formula for anti-fibrosis in CKD: nobiletin inhibits Lgals1/PI3K/AKT signaling to improve renal fibrosis.筛选 和 配方中的活性成分以防治 CKD 中的纤维化:川陈皮素通过抑制 Lgals1/PI3K/AKT 信号通路改善肾脏纤维化。
Ren Fail. 2024 Dec;46(2):2375033. doi: 10.1080/0886022X.2024.2375033. Epub 2024 Jul 5.
半乳糖凝集素-1通过IFN-β促进巨噬细胞重编程和炎症消退。
Front Pharmacol. 2020 Jun 17;11:901. doi: 10.3389/fphar.2020.00901. eCollection 2020.
4
A Pro-resolving Role for Galectin-1 in Acute Inflammation.半乳糖凝集素-1在急性炎症中的促消退作用。
Front Pharmacol. 2020 Mar 20;11:274. doi: 10.3389/fphar.2020.00274. eCollection 2020.
5
Glucocorticoid-transactivated TSC22D3 attenuates hypoxia- and diabetes-induced Müller glial galectin-1 expression via HIF-1α destabilization.糖皮质激素激活的 TSC22D3 通过 HIF-1α 失稳来减轻低氧和糖尿病诱导的 Müller 胶质细胞半乳糖凝集素-1 的表达。
J Cell Mol Med. 2020 Apr;24(8):4589-4599. doi: 10.1111/jcmm.15116. Epub 2020 Mar 9.
6
Increased circulating galectin-1 levels are associated with the progression of kidney function decline in patients undergoing coronary angiography.循环半乳糖凝集素-1 水平升高与接受冠状动脉造影检查的患者肾功能下降的进展相关。
Sci Rep. 2020 Jan 29;10(1):1435. doi: 10.1038/s41598-020-58132-1.
7
Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression.甜蜜的癌症特征:半乳糖凝集素作为肿瘤进展的多功能介质。
J Exp Med. 2020 Feb 3;217(2). doi: 10.1084/jem.20182041.
8
IFN-β is a macrophage-derived effector cytokine facilitating the resolution of bacterial inflammation.IFN-β 是一种由巨噬细胞产生的效应细胞因子,有助于细菌炎症的消退。
Nat Commun. 2019 Aug 2;10(1):3471. doi: 10.1038/s41467-019-10903-9.
9
Galectin-1 studies in proliferative diabetic retinopathy.半乳糖凝集素-1 在增殖性糖尿病视网膜病变中的研究。
Acta Ophthalmol. 2020 Feb;98(1):e1-e12. doi: 10.1111/aos.14191. Epub 2019 Jul 18.
10
MicroRNA-130a has pro-fibroproliferative potential in hypertrophic scar by targeting CYLD.microRNA-130a 通过靶向 CYLD 在肥厚性瘢痕中具有促纤维增生潜能。
Arch Biochem Biophys. 2019 Aug 15;671:152-161. doi: 10.1016/j.abb.2019.07.003. Epub 2019 Jul 5.